KRAS and colorectal carcinoma: The MSI phenotype mediates the mutation of CRC genes, particularly BRAF and MRE11A, as well as other genes such as KRAS, of which clinical researchers are increasingly interested in the genetic mutation of CRC, largely because of its important role in the development of tumors and its potential therapeutic targets and value (Vogelstein et al., 1989).